Hexahydro-1,4-diazepine → HCID 178515205, compound
Reaction equation
[C:1]1([N:7]2[C:25](=[O:26])[C:10]3=[CH:11][NH:12][C:13]4[CH:14]=[CH:15][C:16]([N:19]5[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]5)=[N:17][C:18]=4[C:9]3=[N:8]2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.N1CCCNC[CH2:28]1>>[N:19]1([C:16]2[CH:15]=[CH:14][C:13]3[NH:12][CH:11]=[C:10]4[C:25](=[O:26])[N:7]([C:1]5[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=5)[N:8]=[C:9]4[C:18]=3[N:17]=2)[CH2:20][CH2:21][CH2:28][NH:22][CH2:23][CH2:24]1Participants
3
Procedure
The title compound was prepared following the procedure described for 6a using perhydro-[1,4]-diazepine instead of piperazine. 1H-NMR (DMSO-d6) δ (ppm): 1.82 (2H, m), 2.65 (2H, m), 2.90 (2H, m), 3.88 (4H, m), 6.89 (1H, d, J=9.07 Hz), 7.05 (1H, t, J=7.41 Hz), 7.35 (2H, dd, J=8.52, 7.41 Hz), 7.74 (1H, d, J=9.07 Hz), 8.25 (2H, m), 8.29 (1H, s). m/z 361.4 (MH+).
Sources & evidence
- ORD record
- ord-203df5428173495ea27f8f1f29bbdf99
- Source dataset
- uspto-grants-2010_12
- Patent number
- US07858614B2
Reaction notes
Loading…